104 studies found for:    "Choreatic Disorders" OR "McLeod neuroacanthocytosis syndrome" OR "Neuroacanthocytosis" OR "Chorea Acanthocytosis Syndromes"
Show Display Options
RSS Create an RSS feed from your search for:
"Choreatic Disorders" OR "McLeod neuroacanthocytosis syndrome" OR "Neuroacanthocytosis" OR "Chorea Acanthocytosis Syndromes"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Heart and Skeletal Muscle Problems in Neuroacanthocytosis
Condition: Choreatic Disorder
Intervention:
2 Completed Treatment of Huntington's Chorea With Amantadine
Conditions: Chorea;   Huntington's Disease
Intervention: Drug: Amantadine
3 Terminated Efficacy, Safety and Tolerability of AFQ056 in Patients With Huntington's Disease in Reducing Chorea
Conditions: Huntington's Disease;   Chorea
Interventions: Drug: AFQ056;   Drug: Placebo
4 Recruiting Alternatives for Reducing Chorea in HD
Condition: Chorea Associated With Huntington Disease
Intervention: Drug: SD-809
5 Unknown  Intravenous Immunoglobulins as Effective Treatment in Sydenham's Chorea
Conditions: Sydenham Chorea;   Post Streptococcal Movement Disorder
Interventions: Biological: Intravenous immunoglobulin;   Drug: standard interventions penicillin VK and haloperidol
6 Recruiting First Time Use of SD-809 in Huntington Disease
Condition: Chorea
Interventions: Drug: SD-809;   Drug: Placebo
7 Completed
Has Results
Atomoxetine and Huntington's Disease
Conditions: Huntington Disease;   Chorea
Interventions: Drug: atomoxetine;   Drug: Matching Placebo
8 Completed
Has Results
Citalopram to Enhance Cognition in HD
Conditions: Huntington Disease;   Chorea;   Executive Dysfunction
Interventions: Drug: 20mg daily citalopram;   Drug: Placebo
9 Recruiting Botulinum Toxin for the Treatment of Involuntary Movement Disorders
Conditions: Chorea;   Drug Induced Dyskinesia;   Movement Disorder;   Muscular Disease;   Tic Disorder
Intervention:
10 Completed Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia
Conditions: Ataxia;   Chorea;   Dystonia;   Parkinsonism;   Fatigue
Intervention: Drug: amantadine sulphate
11 Completed Efficacy and Safety of Tetrabenazine in Chorea
Condition: Huntington's Disease
Intervention: Drug: tetrabenazine or placebo
12 Recruiting Safety and Efficacy of Bone Marrow Derived MNCs for Treatment of Cells for the Treatment of Hunting Tons Chorea.
Condition: Huntington Disease
Intervention: Biological: autologous Stem Cell
13 Completed Effects of Music Therapy on Huntington's Disease
Condition: Huntington's Disease
Intervention: Behavioral: Music Therapy
14 Unknown  Far Infrared Irradiation for Managing, Control and Treatment of Huntington's Disease (HD)
Condition: Huntington Disease
Intervention: Radiation: Far Infrared Radiation
15 Unknown  Ursodiol in Huntington's Disease
Condition: Huntington Disease
Interventions: Drug: ursodiol;   Drug: placebo
16 Completed An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196
Condition: Huntington's Disease
Interventions: Drug: SEN0014196 (Low Dose);   Drug: SEN0014196 (High Dose);   Drug: Placebo
17 Completed Impact of Xenazine(Tetrabenazine)on Gait and Functional Activity in Individuals With Huntington's Disease
Condition: Huntington's Disease
Intervention:
18 Completed A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease
Condition: Huntington's Disease
Intervention: Drug: SEN0014196
19 Withdrawn Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon
Conditions: Huntington's Disease;   Parkinson's Disease;   Dementia With Lewy Bodies;   Sleep Disorders;   Circadian Dysregulation
Interventions: Drug: Ramelteon;   Drug: Placebo
20 Completed Healthy Volunteer Positron Emission Tomography (PET) Brain Occupancy Study of a Phosphodiesterase 4 (PDE4) Inhibitor in Huntington's Disease
Condition: Huntington Disease
Interventions: Drug: GSK356278;   Drug: Rolipram

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years